The largest database of trusted experimental protocols

3 protocols using ly2109761

1

Cytokine and Inhibitor Preparation Protocol

Check if the same lab product or an alternative is used in the 5 most similar protocols
Recombinant human (rh-)TGF-β1 (Millipore, Burlington, MA, United States), rh-BMP2, rh-BMP4, rh-BMP7, rh-GDF15 and rh-Activin A (all from Peprotech, Rocky Hill, NJ, United States) were dissolved in 0.1% BSA containing PBS and stored as recommended. Galunisertib, LDN-193189, LY2109761 (ApexBio, Houston, TX, United States), dorsomorphin (Biomol, Hamburg, Germany), SIS3, TGFBR1 kinase inhibitor IV (Calbiochem, San Diego, CA, United States), decitabine, K02288 (Selleckchem, Houston, TX, United States), SB431542 hydrate, RepSox (Sigma-Aldrich), GW788388, DMH-1 (Tocris, Bristol, United Kingdom) were dissolved in DMSO (Sigma-Aldrich) and stored according to manufacturer’s recommendations. Recombinant human Type II TGF-β receptor chimeras ACVR2A-Fc, ACVR2B-Fc, BMPR2-Fc, TGFBR2-Fc, and IgG-Fc were purchased from R&D (Minneapolis, MN, United States) and dissolved in 0.1% BSA containing PBS and stored as recommended.
+ Open protocol
+ Expand
2

TGF-β1, Resveratrol, and LY2109761 Protocol

Check if the same lab product or an alternative is used in the 5 most similar protocols
Recombinant human TGF-β1 was obtained from Peprotech (USA). After dissolving in 10 mM citric acid, TGF-β1 was stored at −80°C. Resveratrol and LY2109761 were obtained from ApexBio and all dissolved in DMSO to acquire a storage liquid of 100 mM and 10mM concentration at −20°C.
+ Open protocol
+ Expand
3

Inhibitors Screening in Breast Cancer Cells

Check if the same lab product or an alternative is used in the 5 most similar protocols
MCF7, MDA-MB-231, and SUM-159 cells were cultured in Dulbecco’s Modified Eagle’s Medium (Hyclone, Logan, UT, USA) supplemented with 10% fetal bovine serum (FBS), 100 U/mL penicillin, and 100 mg/mL streptomycin. All cell lines were cultured in a humidified atmosphere of 5% CO2 at 37 °C. For treatments with the following inhibitors, cells were seeded at the same density and allowed to adhere for 24 h under normal conditions before treatment with the indicated concentrations of different inhibitors. The inhibitors including AZD8330 (A8374), SB203580 (A8254), SP600125 (A4604), PS-1145 (B6089), (5Z)-7-Oxozeaenol (B7443), MK2206 (A3010), LY2109761 (A8464), and Cyclo-RGDfK (A8164) were purchased from APExBIO (Houston, TX, USA). Belvarafenib (S8853) was purchased from Selleck Chemicals (Houston, TX, USA), and UK122 (sc-356185) was purchased from Santa Cruz Biotechnology (Santa Cruz, CA, USA).
+ Open protocol
+ Expand

About PubCompare

Our mission is to provide scientists with the largest repository of trustworthy protocols and intelligent analytical tools, thereby offering them extensive information to design robust protocols aimed at minimizing the risk of failures.

We believe that the most crucial aspect is to grant scientists access to a wide range of reliable sources and new useful tools that surpass human capabilities.

However, we trust in allowing scientists to determine how to construct their own protocols based on this information, as they are the experts in their field.

Ready to get started?

Sign up for free.
Registration takes 20 seconds.
Available from any computer
No download required

Sign up now

Revolutionizing how scientists
search and build protocols!